The mission of the Howard T. Ricketts Laboratory is to carry out cutting-edge research aimed at creating novel therapeutics for biodefense-related and emerging infectious diseases. This research is carried out with the highest possible standards for personnel safety and ethical treatment of animals. The HTRL develops superior models for infectious diseases and provides technologies that are not readily available in Level 3 containment.

The HTRL aims to produce the highest quality and most interesting science in host-pathogen biology that leads to the creation of vaccines and novel antimicrobial therapies for biodefense-related and emerging infectious diseases.

The HTRL aims to support local, state, regional and federal activities in times of crisis. HTRL resources will be available to provide facilities and scientific expertise to first responders in the event of a national emergency.